Management of new onset atrial fibrillation.
McNamara
R L
RL
Bass
E B
EB
Miller
M R
MR
Segal
J B
JB
Goodman
S N
SN
Kim
N L
NL
Robinson
K A
KA
Powe
N R
NR
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D000925:Anticoagulants / Q000008:administration & dosage*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D015897:Comorbidity; D003661:Decision Support Techniques; D004452:Echocardiography; D004554:Electric Countershock / Q000379:methods*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D017678:Sex Distribution; D015996:Survival Rate; D013923:Thromboembolism / Q000453:epidemiology / Q000517:prevention & control*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D001241:Aspirin